Stupp, R; Picard, M; Weller, M (2014). Does cilengitide deserve another chance?-Authors' reply. Lancet Oncology, 15(13):e585-e586.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Oncology |
Language: | English |
Date: | December 2014 |
Deposited On: | 26 Jan 2015 08:25 |
Last Modified: | 26 Jan 2022 04:53 |
Publisher: | Elsevier |
ISSN: | 1470-2045 |
OA Status: | Closed |
Publisher DOI: | https://doi.org/10.1016/S1470-2045(14)71121-0 |
PubMed ID: | 25456377 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-104738
Download
- Content: Published Version
- Permission: Download for registered users
Links
Authors, Affiliations, Collaborations

UniversitatsSpital Zurich, Zurich, Switzerland
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
Merck KGaA, Darmstadt, Germany
UniversitatsSpital Zurich, Zurich, Switzerland
European Organisation for Research and Treatment of Cancer, Brussels, Belgium
European Organisation for Research and Treatment of Cancer, Brussels, Belgium